Abstract Details
|
Eric T. Wong, MD, FAAN
(Rhode Island Hospital)
PRESENTER |
Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care. |
| Olivia Liang | Ms. Liang has nothing to disclose. |
| Edwin Lok, MS, DABR | Mr. Lok has received personal compensation for serving as an employee of US Oncology. Mr. Lok has received intellectual property interests from a discovery or technology relating to health care. |
| Viva Voong Voong | Ms. Voong has nothing to disclose. |
| Neve Constantine | Miss Constantine has nothing to disclose. |
| Tara Lu (Brown University Health) | No disclosure on file |
| Jerrold Boxerman, MD, PhD | Dr. Boxerman has nothing to disclose. |